Trends in the rapid detection of infective oral diseases
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The rapid detection of bacteria in the oral cavity, its species identification, and bacterial count determination are important to diagnose oral diseases caused by pathogenic bacteria. The existing clinical microbial diagnosis methods are time-consuming as they involve observing patients’ samples under a microscope or culturing and confirming bacteria using polymerase chain reaction (PCR) kits, making the process complex. Therefore, it is required to analyze the development status of substances and systems that can rapidly detect and analyze pathogenic microorganisms in the oral cavity. With research advancements, a close relationship between oral and systemic diseases has been identified, making it crucial to identify the changes in the oral cavity bacterial composition. Additionally, an early and accurate diagnosis is essential for better prognosis in periodontal disease. However, most periodontal diseasecausing pathogens are anaerobic bacteria, which are difficult to identify using conventional bacterial culture methods. Further, the existing PCR method takes a long time to detect and involves complicated stages. Therefore, to address these challenges, the concept of point-of-care (PoC) has emerged, leading to the study and implementation of various chair-side test methods. This study aims to investigate the different PoC diagnostic methods introduced thus far for identifying pathogenic microorganisms in the oral cavity. These are classified into three categories: 1) microbiological tests, 2) microchemical tests, and 3) genetic tests. The microbiological tests are used to determine the presence or absence of representative causative bacteria of periodontal diseases, such as A. actinomycetemcomitans , P. gingivalis , P. intermedia , and T. denticola . However, the quantitative analysis remains impossible, and detecting pathogens other than the specific ones is challenging. The microchemical tests determine the activity of inflammation or disease by measuring the levels of biomarkers present in the oral cavity. Although this diagnostic method is based on increase in the specific biomarkers proportional to inflammation or disease progression in the oral cavity, its commercialization is limited due to low sensitivity and specificity. The genetic tests are based on the concept that differences in disease vulnerability and treatment response are caused by the patient’s DNA predisposition. Specifically, the IL-1 gene is used in such tests. PoC diagnostic methods developed to date serve as supplementary diagnostic methods and tools for patient education, in addition to existing diagnostic methods, although they have limitations in diagnosing oral diseases alone. Research on various PoC test methods that can analyze and manage the oral cavity bacterial composition is expected to become more active, aligning with the shift from treatmentoriented to prevention-oriented approaches in healthcare.
Abstract
The rapid detection of bacteria in the oral cavity, its species identification, and bacterial count determination are important to diagnose oral diseases caused by pathogenic bacteria. The existing clinical microbial diagnosis methods are time-consuming as they involve observing patients’ samples under a microscope or culturing and confirming bacteria using polymerase chain reaction (PCR) kits, making the process complex. Therefore, it is required to analyze the development status of substances and systems that can rapidly detect and analyze pathogenic microorganisms in the oral cavity. With research advancements, a close relationship between oral and systemic diseases has been identified, making it crucial to identify the changes in the oral cavity bacterial composition. Additionally, an early and accurate diagnosis is essential for better prognosis in periodontal disease. However, most periodontal diseasecausing pathogens are anaerobic bacteria, which are difficult to identify using conventional bacterial culture methods. Further, the existing PCR method takes a long time to detect and involves complicated stages. Therefore, to address these challenges, the concept of point-of-care (PoC) has emerged, leading to the study and implementation of various chair-side test methods. This study aims to investigate the different PoC diagnostic methods introduced thus far for identifying pathogenic microorganisms in the oral cavity. These are classified into three categories: 1) microbiological tests, 2) microchemical tests, and 3) genetic tests. The microbiological tests are used to determine the presence or absence of representative causative bacteria of periodontal diseases, such as A. actinomycetemcomitans , P. gingivalis , P. intermedia , and T. denticola . However, the quantitative analysis remains impossible, and detecting pathogens other than the specific ones is challenging. The microchemical tests determine the activity of inflammation or disease by measuring the levels of biomarkers present in the oral cavity. Although this diagnostic method is based on increase in the specific biomarkers proportional to inflammation or disease progression in the oral cavity, its commercialization is limited due to low sensitivity and specificity. The genetic tests are based on the concept that differences in disease vulnerability and treatment response are caused by the patient’s DNA predisposition. Specifically, the IL-1 gene is used in such tests. PoC diagnostic methods developed to date serve as supplementary diagnostic methods and tools for patient education, in addition to existing diagnostic methods, although they have limitations in diagnosing oral diseases alone. Research on various PoC test methods that can analyze and manage the oral cavity bacterial composition is expected to become more active, aligning with the shift from treatmentoriented to prevention-oriented approaches in healthcare.
참고문헌 (60)
- Miller WD, "Diseases of the human body which have been traced to the action of mouth-bacteria", Am J Dent Sci, 25, pp.311~319 (1891)
- Emily Read, "The role of oral bacteria in inflammatory bowel disease", Nat Rev Gastroenterol Hepatol, 18(10), pp.731~742 (2021), Springer Science and Business Media LLC[DOI]
- Heidi Tuominen, "Oral Microbiota and Cancer Development", Pathobiology, 88(2), pp.116~126 (2020), S. Karger AG[DOI]
- Yiwen Li, "Oral, Tongue-Coating Microbiota, and Metabolic Disorders: A Novel Area of Interactive Research", Frontiers in Cardiovascular Medicine, 8, pp.730203~ (2021), Frontiers Media SA[DOI]
- Angela R. Kamer, "Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly", Alzheimers Dement, 13(1), pp.e12172~ (2021), Wiley[DOI]
- T.E. Matsha, "Oral Microbiome Signatures in Diabetes Mellitus and Periodontal Disease", Journal of Dental Research, 99(6), pp.658~665 (2020), SAGE Publications[DOI]
- ZeYu Huang, "Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice", Annals of the Rheumatic Diseases, 79(5), pp.646~656 (2020), BMJ[DOI]
- Luz Amparo Gómez, "Porphyromonas gingivalis Placental Atopobiosis and Inflammatory Responses in Women With Adverse Pregnancy Outcomes", Frontiers in Microbiology, 11, pp.591626~ (2020), Frontiers Media SA[DOI]
- N. Takahashi, "The role of bacteria in the caries process:ecological perspectives", Journal of Dental Research, 90(3), pp.294~303 (2010), SAGE Publications[DOI]
- Cu¨neyt Asım Aral, "Alveolar Bone Protective and Hypoglycemic Effects of Systemic Propolis Treatment in Experimental Periodontitis and Diabetes Mellitus", Journal of Medicinal Food, 18(2), pp.195~201 (2015), 한국식품영양과학회[DOI]
- Jørgen Slots, "Subgingival microflora and periodontal disease", Journal of Clinical Periodontology, 6(5), pp.351~382 (1979), Wiley[DOI]
- A. D. Haffajee, "Microbial complexes in supragingival plaque", Oral Microbiology and Immunology, 23(3), pp.196~205 (2008), Wiley[DOI]
- "Consensus Report Periodontal Diseases: Pathogenesis and Microbial Factors", Annals of Periodontology, 1(1), pp.926~932 (1996), Wiley[DOI]
- Lee YH, "Saliva : an emerging biofluid for early detection of diseases", Am J Dent, 22, pp.241~248 (2009)
- Monika Naginyte, "Enrichment of periodontal pathogens from the biofilms of healthy adults", Scientific Reports, 9(1), pp.5491~ (2019), Springer Science and Business Media LLC[DOI]
- Casey Chen, "Microbiological tests for Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis", Periodontology 2000, 20(1), pp.53~64 (1999), Wiley[DOI]
- Bruce J. Paster, "Molecular microbial diagnosis", Periodontology 2000, 51(1), pp.38~44 (2009), Wiley[DOI]
- Mangala A Nadkarni, "Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set", Microbiology, 148(1), pp.257~266 (2002), Microbiology Society[DOI]
- Hwa-Sook Kim, "Development of Strain-specific PCR Primers Based on a DNA Probe Fu12 for the Identification of Fusobacterium nucleatum subsp. nucleatum ATCC 25586T", The Journal of Microbiology, 43(4), pp.331~336 (2005), 한국미생물학회
- William V. Giannobile, "Saliva as a diagnostic tool for periodontal disease: current state and future directions", Periodontology 2000, 50(1), pp.52~64 (2009), Wiley[DOI]
- W. M. M. Jenkins, "Longitudinal study of untreated periodontitis", Journal of Clinical Periodontology, 15(5), pp.324~330 (1988), Wiley[DOI]
- L. J. Brown, "Periodontal Diseases in the U.S. In 1981: Prevalence, Severity, Extent, and Role in Tooth Mortality", Journal of Periodontology, 60(7), pp.363~370 (1989), Wiley[DOI]
- U. Van der Veiden, "Prevalence of periodontal breakdown in adolescents and presence of Actinobacillus actinomycetemcomitans in subjects with attachment loss", Journal of Periodontology, 60(11), pp.604~610 (1989), Wiley[DOI]
- Roberto Andrade, "Intra- and inter-examiner reproducibility of manual probing depth", Brazilian Oral Research, 26(1), pp.57~63 (2012), FapUNIFESP (SciELO)[DOI]
- Lafzi A, "Assessment of intra-and inter-examiner reproducibility of probing depth measurements with a manual periodontal probe", J Dent Res Dent Clin Dent Prospects, 1, pp.19~25 (2007)[DOI]
- 김민정, "Strain-specific PCR Primers for the Detection of Prevotella intermedia ATCC 49046", International Journal of Oral Biology, 36(2), pp.79~82 (2011), 대한구강생물학회
- Curtis MA, "Detection of highrisk groups and individuals for periodontal diseases : laboratory markers from analysis of gingival crevicular fluid", J Clin Periodontol, 16, pp.1~11 (1989)[DOI]
- Biomarkers Definitions Working Group, "Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework", Clin Pharmacol Ther, 69(3), pp.89~95 (2001), Wiley[DOI]
- Nancy Srivastava, "Point of Care- A Novel Approach to Periodontal Diagnosis-A Review", JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 11, pp.ZE01~ZE06 (2017), JCDR Research and Publications[DOI]
- Sarhang S. Gul, "Diagnostic Accuracy of Oral Fluids Biomarker Profile to Determine the Current and Future Status of Periodontal and Peri-Implant Diseases", Diagnostics, 10(10), pp.838~ (2020), MDPI AG[DOI]
- Miller SM, "Saliva testing--a nontraditional diagnostic tool", Clin Lab Sci, 7, pp.39~44 (1994)
- KrishnanChandragiri Subbarao, "Gingival crevicular fluid: An overview", Journal of Pharmacy And Bioallied Sciences, 11(Suppl 2), pp.S135~S139 (2019), Medknow[DOI]
- Catherine M. E. Champagne, "Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases", Periodontology 2000, 31(1), pp.167~180 (2003), Wiley[DOI]
- Zia A, "Oral biomarkers in the diagnosis and progression of periodontal diseases", Biol Med(Aligarh), 3, pp.45~52 (2011)
- Iain L. C. Chapple, "Periodontal diagnosis and treatment – where does the future lie?", Periodontology 2000, 51(1), pp.9~24 (2009), Wiley[DOI]
- Kaklamanos EG, "A review on peri-implant crevicular fluid assays potential in monitoring and predicting periimplant tissue responses", J Int Acad Periodontol, 4, pp.49~59 (2002)
- Erhan Dursun, "Peri-Implant Crevicular Fluid Analysis, Enzymes and Biomarkers: a Systemetic Review", Journal of Oral and Maxillofacial Research, 7(3), pp.e9~ (2016), Stilus Optimus[DOI]
- Frederick A. Kuehl, "Prostaglandins, Arachidonic Acid, and Inflammation", Science, 210(4473), pp.978~984 (1980), American Association for the Advancement of Science (AAAS)[DOI]
- Steven Offenbacher, "Modulation of host PGE2 secretion as a determinant of periodontal disease expression", Journal of Periodontology, 64(5S), pp.432~444 (1993), Wiley[DOI]
- Koichi Nakashima, "Osteocalcin, prostaglandin E2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status", Journal of Clinical Periodontology, 21(5), pp.327~333 (1994), Wiley[DOI]
- NRavindra Reddy, "Estimation of prostaglandin E2 levels in gingival crevicular fluid in periodontal health, disease and after treatment", Contemporary Clinical Dentistry, 4(3), pp.303~306 (2013), Medknow[DOI]
- Takeuchi O, "Pattern recognition receptors and inflammation", Cell, 140, pp.805~820 (2010)[DOI]
- Cheng R, "Interleukin-1β is a potential therapeutic target for periodontitis : a narrative review", Int J Oral Sci, 12, pp.2~ (2020)[DOI]
- Rangbulla V, "Salivary IgA, Interleukin-1β and MMP-8 as salivary biomarkers in chronic periodontitis patients", Chin J Dent Res, 20, pp.43~51 (2017)[DOI]
- Schett G, "Interleukin-1 function and role in rheumatic disease", Nat Rev Rheumatol, 12, pp.14~24 (2016)[DOI]
- Cem Gabay, "Interleukin-6 and chronic inflammation", Arthritis Res Ther, 8(Suppl 2), pp.S3~ (2006), Springer Science and Business Media LLC[DOI]
- Husniah Batool, "Salivary Levels of IL-6 and IL-17 Could Be an Indicator of Disease Severity in Patients with Calculus Associated Chronic Periodontitis", BioMed Research International, 2018, pp.1~5 (2018), Hindawi Limited[DOI]
- Y Hosokawa, "Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin", Clinical and Experimental Immunology, 142(2), pp.285~291 (2005), Oxford University Press (OUP)[DOI]
- EA Roberts, "Profile of Cytokine mRNA Expression in Chronic Adult Periodontitis", Journal of Dental Research, 76(12), pp.1833~1839 (1997), SAGE Publications[DOI]
- T Sorsa, "Matrix metalloproteinases (MMPs) in oral diseases", Oral Diseases, 10(6), pp.311~318 (2004), Wiley[DOI]
- Timo Sorsa, "Analysis of matrix metalloproteinases, especially MMP‐8, in gingival crevicular fluid, mouthrinse and saliva for monitoring periodontal diseases", Periodontology 2000, 70(1), pp.142~163 (2015), Wiley[DOI]
- Timo Sorsa, "MMP activation in diagnostics of periodontitis and systemic inflammation", Journal of Clinical Periodontology, 38(9), pp.817~819 (2011), Wiley[DOI]
- R W Peeling, "Rapid tests for sexually transmitted infections (STIs): the way forward", Sexually Transmitted Infections, 82(suppl_5), pp.v1~v6 (2006), BMJ[DOI]
- Chepuri T, "Chair Side Diagnostic Test Kits in Periodontics", Indian Journal of Dental Advancements, 07(01), pp.41~45 (2015), National Academy of Dentistry[DOI]
- Nabors TW, "Salivary testing for periodontal disease diagnosis and treatment", Dent Today, 29, pp.53~54 (2010)
- Wanghong He, "Point-of-Care Periodontitis Testing: Biomarkers, Current Technologies, and Perspectives", Trends in Biotechnology, 36(11), pp.1127~1144 (2018), Elsevier BV[DOI]
- G. Rutger Persson, "Relationship between levels of aspartate aminotransferase in gingival crevicularfluid and gingival inflammation", Journal of Periodontal Research, 25(1), pp.17~24 (1990), Wiley[DOI]
- Gary C. Armitage, "Longitudinal Evaluation of Elastase as a Marker for the Progression of Periodontitis", Journal of Periodontology, 65(2), pp.120~128 (1994), Wiley[DOI]
- Timo Sorsa, "A quantitative point-of-care test for periodontal and dental peri-implant diseases", Nature Reviews Disease Primers, 3(1), pp.17069~ (2017), Springer Science and Business Media LLC[DOI]
- Buduneli N, "Biomarkers in periodontal health and disease: rationale, benefits, and future directions" (2020), Springer International Publishing
